
ç¿çã¯ãã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ãæäžãããåœã§ã®ã¿çºçãããã¯ãã¯ã©ãŒãç倧ãªã»ããã®æšé²ã«å©çšãããŠããã
2022幎5æäžæ¬é ãããäž»èŠã¡ãã£ã¢ã§ãMonkeypoxããšããèšèãäœåºŠãè³ã«ãããç®ã«ãããããããšãå€ããªããŸããã
幎以äžåã«ã¢ããªã«ã§çºèŠãããŠä»¥æ¥åããŠããµã«çãŠã€ã«ã¹ãã¢ã¡ãªã«ãã€ã®ãªã¹ãã«ããããã©ãžã«ããªãŒã¹ãã©ãªã¢ããšãŒãããã®ã»ãšãã©ã®åœã ã§åæã«æµè¡ããŠãããšèšãããŠããã
ããããå¶ç¶ã«ãããµã«çãæµè¡ããŠãããšããããã¹ãŠã®åœãããã¡ã€ã¶ãŒç€Ÿã®ãã³ããã19ãæ³šå°ãåœæ°ã«é åžããŠããåœã§ããããéå»50幎ããŸãã®éããã®ç æ°ãæµè¡ããŠããã¢ããªã«ã®äžéšã®åœãé€ããŠã¯ã
äžçä¿å¥æ©é¢ã¯ããã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ãæäžãããªãã£ãäžçã®ã©ã®åœãããããµã«çã®å ±åãäžä»¶ãåããŠããªãã
ãªãã ããïŒ
ããã¯ãéå»2幎éã«äžçã襲ã£ã2åç®ã®ãã³ãããã¯ãç®æããŠããããã§ã¯æããŠãããŸããã
å ç«ç³»ã«èšãç¥ããªããã¡ãŒãžãäžããå®éšçãªmRNA泚å°ãäœçŸäžäººãã®äººã ã«è¡ã£ãçµæãç®ã®åœããã«ããŠããããã§ãããå ¬è¡è¡çåœå±ã¯çŸåšãã³ãã19ã¯ã¯ãã³ã«ãã垯ç¶ç±ç¹ãé èœããããšèºèµ·ã«ãªã£ãŠãã倧ãªã»ãããã宿œãããšããæè¡ç課é¡ãé²ããæ©äŒãšããŠãããå©çšããŠãããããªã®ã ã
äžã®ç»åãã¯ãªãã¯ããŠã2022幎5æä»¥éãã©ã®åœãW.H.O.ã«ç¿çã®çäŸãå ±åããã©ã®åœããã¡ã€ã¶ãŒç€Ÿã®ã³ããã19泚å°ãé åžããŠãããããã£ãããšæ¯èŒããŠã¿ãŠãã ããã

ç¿çã®çäŸãå ±åãããåœã¯ãã¹ãŠãã¡ã€ã¶ãŒç€Ÿã®ãžã£ããé åžããŠããããããŠããã¡ã€ã¶ãŒã®ãžã£ããæäžãããåœã®äžã§ããµã«çã®çäŸãW.H.O.ã«å ±åããŠããªãåœã¯ã»ãã®äžæ¡ãã§ããã
ããã®ãµã«çã¯ã1970幎ã«ã³ã³ãŽæ°äž»å ±ååœã§9æ³ã®ç·å ã«åããŠç¢ºèªãããããã以æ¥ãã¢ããªã«ã®11ã«åœã§ãµã«çã®ããã®çäŸãå ±åãããŠããŸããã¢ããªã«ä»¥å€ã§åããŠãµã«çã®çºçãèšé²ãããã®ã¯2003幎ã§ãããã¯ç±³åœã§ã®ããšã§ããã
50幎ã®éã«ããµã«ã¢ããã¯ã¢ããªã«ã®æ°ã«åœä»¥å€ã§ã¯å šãæµè¡ããªãã£ãã®ã«ãCovid-19ãåºçŸãããšèšãããŠãã2幎以å ã«ããµã«ã¢ãããçªç¶ãã¹ãŠã®è¥¿æŽè«žåœã§æµè¡ããå ¬è¡è¡çåœå±ãäž»èŠã¡ãã£ã¢ãäžçä¿å¥æ©é¢ã«ãã£ãŠå€§ããã«å®£äŒãããŠããã®ã¯äžæè°ã«æããªããïŒ
ç¿çã®çäŸãå ±åãããŠãããã¹ãŠã®åœãããã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ãåœæ°ã«é åžããŠããããšãäžæè°ã«æããªãã®ã ãããïŒ
ãããããã§ãªããªããBBCãã¥ãŒã¹ãèŠãã®ããããŠããã ãããããªããªããããªãã®ç®ã«æ ãäžçã¯ãŸã£ããã®ãã£ã¯ã·ã§ã³ã ããã ã
1988幎ã«çºè¡šãããç§åŠçç ç©¶ã«ããã°ãç¿çãšæ°Žç±ç¡ãåºå¥ããããšã¯äºå®äžäžå¯èœã§ãããæ°Žç±ç¡ã¯æ°Žç垯ç¶ç±ç¹ãŠã€ã«ã¹ã«ãã£ãŠåŒãèµ·ãããããã®è¿çžçš®ã§ããåçŽãã«ãã¹ãŠã€ã«ã¹ãšåæ§ã«ãçæ¶¯ã«ããã£ãŠäœå ã«çãŸãããšã«ãªãã®ã ã
ãããŠãæ°Žçã¯ããäžã€ã®ããšãã§ããæ§åšãã«ãã¹ã®ããã«ãç¥çµçްèã®äžã«æœãã§äœå¹Žãæ²é»ããŠããããšããããåŸã«å掻æ§åããŠãæ°Žã¶ãããç«å·ã䌎ãèãé£ãç®èçŸæ£ã§ãã垯ç¶ç±ç¹ãšãã圢ã§å€§æšäºãåŒãèµ·ããããšããããŸãã

çãããããµã«çããšèšãããŠããã®ã¯ãæ¬åœã¯Covid-19ã¯ã¯ãã³ã«ãããã«ãã¹ææçã垯ç¶ç±ç¹ãèªå·±å ç«æ§æ°Žç±çãªã©ãCovid-19ã¯ã¯ãã³æ¥çš®ã«ããå ç«åã®äœäžãããããç æ°ãªã®ã§ãã
CDC Wonder Vaccine Adverse Event Reporting SystemïŒVAERSïŒããŒã¿ããŒã¹ã«ãããšã2022幎6æ3æ¥çŸåšãCDCã¯ã³ããã-19泚å°ã®å¯åå¿ãšããŠçºçãããã«ãã¹ããã³åž¯ç¶ç±ç¹ææçã«é¢ãã18,026ä»¶ã®å ±åãåŠçããŠãããšã®ããšã§ãã
äžæ¹ãåãVAERSããŒã¿ããŒã¹ã«ãããšãCDCã¯ã2008幎ãã2020幎ã®éã«å©çšå¯èœãªãã¹ãŠã®ã€ã³ãã«ãšã³ã¶äºé²æ¥çš®ã®å¯äœçšãšããŠçºçãããã«ãã¹/垯ç¶ç±ç¹ææçã«é¢ãã1,052ä»¶ã®å ±åããåãåã£ãŠããªãã®ã§ããã
ãã®æ°åã ãã§ããã³ããã-19泚å°ã®ããã«ãã«ãã¹/垯ç¶ç±ç¹ã«é¢ããæå®³äºè±¡ã1,614%å¢å ããããšãåãããŸãã

ããã¯ãCovid-19ã®æ³šå°ãå¢ããããã§ã¯ãããŸããã
CDCã«ãããšã2008幎ãã2020幎ã®éã«17忬ã®Fluãžã£ããæäžãããïŒåºå žïŒããããããOur World in Dataãã«ãããšã2022幎5æ27æ¥çŸåšãç±³åœã§æäžãããCovid-19ã®ãžã£ãã¯5å8804äžæ¬ã«ãšã©ãŸã£ãŠããŸãã

ãã®æ°åãããšã«ã100äžåæäžãããã®ãã«ãã¹ïŒåž¯ç¶ç±ç¹ææçã«é¢ããæå®³äºè±¡ã®çºççãèšç®ããŠã¿ãŸãããã
ãã®çµæã¯æ¬¡ã®éãã§ãã

å ¥æå¯èœãªããŒã¿ã«ãããšãã³ããã19泚å°100äžåæäžãããã®ãã«ãã¹/垯ç¶ç±ç¹ææã«é¢é£ããæå®³äºè±¡ã®çºççã¯ãã€ã³ãã«ãšã³ã¶ã¯ã¯ãã³100äžåæäžãããã®ãã«ãã¹/垯ç¶ç±ç¹ææã«é¢é£ããæå®³äºè±¡ã®çºççãã4925%é«ãããšã瀺ãããŠããŸãã
ãããã£ãŠããã®ç±³åœæ¿åºã®å ¬åŒããŒã¿ã¯ãã³ããã19ã®ã¯ã¯ãã³æ¥çš®ãã人ã®åž¯ç¶ç±ç¹ã®çºçãªã¹ã¯ãå°ãªããšã4925ïŒ å¢å ãããããšã蚌æããŠããã®ã§ãã
FDAã75幎éå ¬è¡šãé ãããããšãããã¡ã€ã¶ãŒã®æ©å¯ææžã«ã¯ãç¿çãšæ¥µããŠé¡äŒŒããããäžã€ã®çç¶ãèªå·±å ç«æ§æ°Žç±çãèšèŒãããŠããã
ãã®çç¶ã¯ããã¡ã€ã¶ãŒã®åçºè¡_5.3.6 postmarketing experience.pdfææžã®æåŸã«ããã9ããŒãžã«åã¶ç¹å¥ãªæå®³äºè±¡ã®ãªã¹ãã«é ãããŠããã®ã§ããã

èªå·±å ç«æ§æ°Žç±çã¯ãå šèº«ã®ç®èãç²èã«æ°Žç±ãã§ããç æ°ã§ããå£ã錻ãåãç®ãçæ®åšãªã©ã䟵ãããããšããããŸãããã®ç æ°ã¯å®å šã«ã¯è§£æãããŠããŸãããããå°éå®¶ãã¯ããã®ç æ°ã«ãªããããéºäŒçåŸåãæã€äººããç°å¢äžã®åŒãéã«æ¥è§Šãããšãã«èªçºããããšèããŠããŸããããã¯ååŠç©è³ªãè¬ãããããªãããã¡ã€ã¶ãŒã®ã³ãã19泚å°ã®ãããªãã®ã§ããïŒ
åããã¡ã€ã¶ãŒç€Ÿã®ææžã«ããã°ããã«ãã¹ãŠã€ã«ã¹ææçã¯ãmRNAã³ãŽã£ã19泚å°ã«é¢é£ããŠç¹ã«æ³šç®ãã¹ãæå®³äºè±¡ãšããŠæããããŠããã

ãã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ãç±³åœãšè±åœã§ç·æ¥äœ¿çšèš±å¯ãåŸãŠããããã2ã¶æåŸã®2021幎2ææ«ãŸã§ã«ããã¡ã€ã¶ãŒç€Ÿã¯ãã«ãã¹ææã«é¢é£ãã8152ä»¶ã®å ±åãåãããã®ãã¡18ä»¶ã¯ãã§ã«å€èåšäžå šçå矀ã«è³ã£ãŠããŸãã
ãªããã¡ã€ã¶ãŒç€Ÿã®ã¯ã¯ãã³ã¯ãæã ãèããããŠããç¿çç ãšé©ãã»ã©é¡äŒŒããç æ°ãåŒãèµ·ããã®ã§ããããïŒããã¯ãèªç¶å ç«ç³»ã壿» ãããããã§ããã
次ã®ã°ã©ãã¯ãè±åœå¥åº·å®å šä¿éå±ã®2022幎ã®ç¬¬3é±ã第7é±ã第13é±COVID-19ã¯ã¯ãã³ã»ãµãŒãã€ã©ã³ã¹å ±åã«èŠãããããŒã¿ã«ãããšãã€ã³ã°ã©ã³ãã®3åæ¥çš®è ã«ãããCOVID-19ã¯ã¯ãã³å¹æã瀺ããŠãã - ã

ããŒã¿ã«ãããšãå°ãªããšã2022幎åé ããã¯ã¯ãã³å¹æã¯åææ¯ã§äœäžããŠãããæãäœã广ãèšé²ããã®ã¯60ïœ69æ³ã®ãã€ãã¹391ïŒ ãšããè¡æçãªæ°åã§ããããã®å¹Žéœ¢å±€ã¯ã3é±ç®ã®ãã€ãã¹104.69ïŒ ããäœäžããæãæ¥æ¿ãªæžå°ãçµéšãã幎霢局ã§ããããŸãã
ã¯ã¯ãã³æå¹æ§ããã€ãã¹ã§ããããšã¯ãå ç«ã·ã¹ãã ã®æå·ãæå³ããããªããªããã¯ã¯ãã³æå¹æ§ã¯ãå®éã«ã¯ã³ããã-19ã¯ã¯ãã³ã®æå¹æ§ãç€ºãææšã§ã¯ãªãããã§ãããããã¯ãã¯ã¯ãã³æ¥çš®ãåãã人ã®å ç«ã·ã¹ãã ã®ããã©ãŒãã³ã¹ããã¯ã¯ãã³æªæ¥çš®ã®äººã®å ç«ã·ã¹ãã ã®ããã©ãŒãã³ã¹ãšæ¯èŒããææšã§ãã
ãªãã³ããã-19ã¯ã¯ãã³ã®ææšã«ãªããªãã®ã§ããããïŒãªããªãããã®æ³šå°ã¯ç§ãã¡ã®çްèã«äŸµå ¥ããDNAãæäœããŠããªãªãžãã«ã®SARS-CoV-2ãŠã€ã«ã¹ã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªãšããããã®ãäœçŸäžãšäœãåºãããæç€ºããããã§ãããããŠãå ç«ã·ã¹ãã ã¯ãããã®ã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªãäœå€ã«æåºããããšããããå°æ¥SARS-CoV-2ãŠã€ã«ã¹ã«ééããå Žåãåã³ãããè¡ãããšãèŠããŠããã¯ãã ãšããçè«ã§ããã
ãããäžèšã®UKHSAã®ããŒã¿ã蚌æããããã«ãå ç«ã·ã¹ãã ããããè¡ããªãã°ããããã¯ã¯ãã³æªæ¥çš®ã®äººã®å ç«ã·ã¹ãã ãããã¯ããã«æªãä»äºãããŠãããšããã°ãããã¯ã³ããã19泚å°ãé·æã«ããã£ãŠå ç«ã·ã¹ãã ã«ãã¡ãŒãžãäžããäžãç¶ããŠããããšãæå³ããŸãã
ãã®çµæããã«ãã¹ææãåçãã垯ç¶ç±ç¹ãèªå·±å ç«æ§æ°Žç±çãå€èåšäžå šçå矀ãªã©ã®çç¶ãåŒãèµ·ãããããªãã¯ãããç¿çã§ãããšèšãããŠããã®ã§ãã
ããããããã¯é èœã®ããã«èšãããŠããã®ã§ã¯ãªããåœå±ãæè¡çãªè°é¡ãé²ããããã«äœ¿ã£ãŠããã®ã ã
æ¿æ²»å®¶ãäŒæ¥ã®ãªãŒããŒãã¡ã®é ããåçã¯ãåœå®¶çµæžã厩å£ãããã°ããŒãã«ãªããžã¿ã«é貚ãå°å ¥ããéãéãç®çã§ãCovid-19ã®ãã³ãããã¯çæãæªçšããã®ã ããããã®æå°è ã«ã¯ããã©ã³ã¹ã®ãšããã¥ãšã«ã»ãã¯ãã³å€§çµ±é ãã«ããã®ãžã£ã¹ãã£ã³ã»ãã«ããŒéŠçžããã¥ãŒãžãŒã©ã³ãã®ãžã£ã·ã³ãã»ã¢ãŒããŒã³éŠçžãè±åœã®ããªã¹ã»ãžã§ã³ãœã³éŠçžãå«ãŸããã
"Monkeypox "ã¯ã圌ããææã®ãã£ã³ããŒã³ãåå°å ¥ãããããªã匷硬ãªå¶éã宿œããããšãå¯èœã«ããç§ãã¡å šå¡ãåœç¶ãšæã£ãŠããåºæ¬çäººæš©ãæ°žé ã«å€±ãããããžã¿ã«ID/瀟äŒçä¿¡çšã·ã¹ãã ã®å®æœãžã®å笊ãšãªãã®ã§ãã
ä»å¹Žã«å ¥ã£ãŠãããå€ãã®åœããªã³ã©ã€ã³æ€é²ã®æ¡å€§ãå®è³ªçãªç€ŸäŒä¿¡çšã·ã¹ãã ã®å°å ¥ãããžã¿ã«ã¢ã€ãã³ãã£ãã£ã®å°å ¥èšç»ãçºè¡šããåœå®¶ããžã¿ã«é貚ã®å°å ¥ãšããã¢ã€ãã¢ãæµ®äžããŠããŸãã
以äžã¯ããã®äžäŸã«é¢ããèšäºã®ãªã¹ãã§ããã
Vienna Is Also Becoming a Testing Ground for A Chinese-Style Social Credit System
Within Days of Macronâs Re-Election France Rolls Out Digital ID
ãããããããããŸãããã«ã¯ãäžççµæžãã©ãŒã©ã ã®ãã¯ãã¯ã©ãŒãïŒæ å ±æºïŒãå ¥ã蟌ãã§ããåœå±ããåœæ°ã峿¹ã«ã€ããå¿ èŠãããã®ã ã
ãããŠåœŒãã¯ãéå»2幎éã«ãããCovid-19ã®å¶éã倧倿°ã®äººã ãçãããšãªãéµå®ããŠããããšãéããŠãç¹ã«è²·åããŠéãæã£ãäž»æµã¡ãã£ã¢ãããã°ããããåé¡ã«ã¯ãªããªãããšãç¥ã£ãŠããã®ã ã